Literature DB >> 12399767

Photodynamic therapy with 5-aminolevulinic acid for recalcitrant familial benign pemphigus (Hailey-Hailey disease).

Ricardo Ruiz-Rodriguez1, J G Alvarez, P Jaén, A Acevedo, S Córdoba.   

Abstract

Familial benign pemphigus is a chronic, recurrent, autosomal dominant blistering disease that may significantly affect quality of life. Surgical methods are often needed to control flares in difficult cases. We describe the use of photodynamic therapy (PDT) with topical 5-aminolevulinic acid (ALA) followed by irradiation with incoherent light (ALA-PDT) in 2 patients with chronic, recalcitrant familial benign pemphigus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12399767     DOI: 10.1067/mjd.2002.124802

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

1.  Weepy pruritic rash in the groin.

Authors:  Jennifer Clay Cather; Lauren Hoffman
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-10

2.  Chronic vulvocrural dermatitis with burning and itching.

Authors:  Maria Le Donne; Maria Lentini; Giovanna Moretti; Serafinella Patrizia Cannavò
Journal:  CMAJ       Date:  2008-09-09       Impact factor: 8.262

3.  [Disseminated M. Hailey-Hailey].

Authors:  D Richter-Hintz; M Megahed
Journal:  Hautarzt       Date:  2003-03-07       Impact factor: 0.751

4.  Successful treatment of hailey-hailey disease with aminolevulinic Acid photodynamic therapy.

Authors:  Xiao Xiao Yan; Hong Qing Tian; Chang Liang Wang; Bao Qi Yang; Wei Zhi Wu; Fu Ren Zhang
Journal:  Ann Dermatol       Date:  2015-03-24       Impact factor: 1.444

5.  Hailey-hailey disease on sun-exposed areas.

Authors:  Angoori Gnaneshwar Rao
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494

Review 6.  Management of familial benign chronic pemphigus.

Authors:  Harleen Arora; Fleta N Bray; Jessica Cervantes; Leyre A Falto Aizpurua
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-09-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.